|Chimeric antigen receptor T cells for sustained remissions in leukemia|
SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ...
New England Journal of Medicine 371 (16), 1507-1517, 2014
|Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia|
DL Porter, WT Hwang, NV Frey, SF Lacey, PA Shaw, AW Loren, A Bagg, ...
Science translational medicine 7 (303), 303ra139-303ra139, 2015
|Linezolid for treatment of chronic extensively drug-resistant tuberculosis|
M Lee, J Lee, MW Carroll, H Choi, S Min, T Song, LE Via, LC Goldfeder, ...
New England Journal of Medicine 367 (16), 1508-1518, 2012
|Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia|
DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ...
Cancer discovery 6 (6), 664-679, 2016
|GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity|
MA Spinner, LA Sanchez, AP Hsu, PA Shaw, CS Zerbe, KR Calvo, ...
Blood 123 (6), 809-821, 2014
|Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems|
DR Prevots, PA Shaw, D Strickland, LA Jackson, MA Raebel, MA Blosky, ...
American journal of respiratory and critical care medicine 182 (7), 970-976, 2010
|Adult-onset immunodeficiency in Thailand and Taiwan|
SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ...
New England Journal of Medicine 367 (8), 725-734, 2012
|Exact and asymptotic weighted logrank tests for interval censored data: the interval R package|
MP Fay, PA Shaw
Journal of statistical software 36 (2), 2010
|Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative|
ML Neuhouser, L Tinker, PA Shaw, D Schoeller, SA Bingham, LV Horn, ...
American journal of epidemiology 167 (10), 1247-1259, 2008
|Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia|
JC Fitzgerald, SL Weiss, SL Maude, DM Barrett, SF Lacey, JJ Melenhorst, ...
Critical care medicine 45 (2), e124, 2017
|Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors|
DI Zonios, J Falloon, JE Bennett, PA Shaw, D Chaitt, MW Baseler, ...
Blood, The Journal of the American Society of Hematology 112 (2), 287-294, 2008
|Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model|
MJ Memoli, PA Shaw, A Han, L Czajkowski, S Reed, R Athota, T Bristol, ...
MBio 7 (2), 2016
|Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations|
S Price, PA Shaw, A Seitz, G Joshi, J Davis, JE Niemela, K Perkins, ...
Blood, The Journal of the American Society of Hematology 123 (13), 1989-1999, 2014
|Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program|
BB Poindexter, R Feng, B Schmidt, JL Aschner, RA Ballard, A Hamvas, ...
Annals of the American Thoracic Society 12 (12), 1822-1830, 2015
|Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial|
RD Etzioni, N Howlader, PA Shaw, DP Ankerst, DF Penson, PJ Goodman, ...
The Journal of urology 174 (3), 877-881, 2005
|Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease|
KN Olivier, PA Shaw, TS Glaser, D Bhattacharyya, M Fleshner, CC Brewer, ...
Annals of the American Thoracic Society 11 (1), 30-35, 2014
|The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi|
MW Jewett, K Lawrence, AC Bestor, K Tilly, D Grimm, P Shaw, ...
Molecular microbiology 64 (5), 1358-1374, 2007
|Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991–1998|
R Etzioni, KM Berry, JM Legler, P Shaw
Urology 59 (2), 251-255, 2002
|Durable remissions in children with relapsed/refractory all treated with t cells engineered with a CD19-targeted chimeric antigen receptor (CTL019)|
SA Grupp, SL Maude, PA Shaw, R Aplenc, DM Barrett, C Callahan, ...
Blood, The Journal of the American Society of Hematology 126 (23), 681-681, 2015
|Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL.|
SL Maude, DT Teachey, SR Rheingold, PA Shaw, R Aplenc, DM Barrett, ...
Journal of Clinical Oncology 34 (15_suppl), 3011-3011, 2016